tradingkey.logo

tradingkey.logo
怜玢


Mesa Laboratories Inc

MLAB
りォッチリストに远加
139.010USD
+3.810+2.82%
終倀 11-13 16:00ET
778.46M時䟡総額
212.00盎近12ヶ月PER
時間倖取匕 18:57 (ET)139.020USD-0.310-0.22%

Mesa Laboratories Incに぀いお 䌁業名

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.

Mesa Laboratories Inc プロフィヌル


䌁業コヌドMLAB
䌚瀟名Mesa Laboratories Inc
䞊堎日Feb 29, 1984
最高経営責任者「CEO」Owens (Gary M)
埓業員数730
蚌刞皮類Ordinary Share
決算期末Feb 29
本瀟所圚地12100 W 6th Ave
郜垂LAKEWOOD
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号80228
電話番号13039878000
りェブサむトhttps://mesalabs.com
䌁業コヌドMLAB
䞊堎日Feb 29, 1984
最高経営責任者「CEO」Owens (Gary M)

Mesa Laboratories Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+7.80%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
64.55K
-1.86%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
37.68K
-10.66%
Mr. Mark Christopher Capone
Mr. Mark Christopher Capone
Independent Director
Independent Director
6.21K
+44.81%
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Operations and Continuous Improvement
Senior Vice President - Operations and Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. R. Tony Tripeny
Mr. R. Tony Tripeny
Independent Director
Independent Director
--
--
Dr. Siddhartha Kadia, Ph.D.
Dr. Siddhartha Kadia, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+7.80%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
64.55K
-1.86%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
37.68K
-10.66%
Mr. Mark Christopher Capone
Mr. Mark Christopher Capone
Independent Director
Independent Director
6.21K
+44.81%
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--

よくある質問

Mesa Laboratories Incの䞊䜍5名の株䞻は誰ですか


Mesa Laboratories Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Gary M. Owens

Mesa Laboratories IncMLABの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Mesa Laboratories Incの株匏を保有しおいる機関は397瀟あり、保有株匏の総垂堎䟡倀は玄5.55Mで、党䜓の100.49%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-254194.00増加しおいたす。

Mesa Laboratories Incの最倧の収益源は䜕ですか


2026Q1においお、Discrete Revenues- Consumables郚門がMesa Laboratories Incにずっお最倧の収益を生み出しおおり、その金額は34.78Mで、党収益の57.83%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。